Randomized Study of Abemaciclib Combined with Standard Adj Endocrine Therapy vs Standard Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, HR+, HER2 Neg, Breast Cancer (B58)

Randomized Study of Abemaciclib Combined with Standard Adj Endocrine Therapy vs Standard Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, HR+, HER2 Neg, Breast Cancer (B58)

Trial Category:
Breast
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Hematology Oncology, Lincoln, NE
Southeast Nebraska Cancer Center, Lincoln, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members